Skip to main content
Erschienen in: Virology Journal 1/2023

Open Access 01.12.2023 | Brief Report

Visualization of SARS-CoV-2 particles in naso/oropharyngeal swabs by thin section electron microscopy

verfasst von: Michael Laue, Tobias Hoffmann, Janine Michel, Andreas Nitsche

Erschienen in: Virology Journal | Ausgabe 1/2023

Abstract

Background

SARS-CoV-2 replicates efficiently in the upper airways of humans and produces high loads of virus RNA and, at least in the initial phase after infection, many infectious virus particles. Studying virus ultrastructure, such as particle integrity or presence of spike proteins, and effects on their host cells in patient samples is important to understand the pathogenicity of SARS-CoV-2.

Methods

Suspensions from swab samples with a high load of virus RNA (Ct < 20) were sedimented by desktop ultracentrifugation and prepared for thin section electron microscopy using a novel method which is described in detail. Embedding was performed in Epon or in LR White resin using standard or rapid protocols. Thin sections were examined using transmission electron microscopy.

Results

Virus particles could be regularly detected in the extracellular space, embedded in a background of heterogenous material (e.g. vesicles and needle-like crystals), and within ciliated cells. Morphology (i.e. shape, size, spike density) of virus particles in the swab samples was very similar to particle morphology in cell culture. However, in some of the samples the virus particles hardly revealed spikes. Infected ciliated cells occasionally showed replication organelles, such as double-membrane vesicles. The most common cells in all samples were keratinocytes from the mucosa and bacteria.

Conclusions

The new method allows the ultrastructural visualization and analysis of coronavirus particles and of infected host cells from easy to collect naso/oropharyngeal patient swab samples.
Begleitmaterial
Additional file 1: Video S1. Recovery of the sediment after ultracentrifugation
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12985-023-01981-9.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
COVID19
Coronavirus disease 2019
EM
Electron microscopy
qRT-PCR
Quantitative real-time polymerase-chain reaction
SARS-CoV-2
Severe acute respiratory syndrome virus 2

Background

The pandemic Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) primarily infects the respiratory tract [1]. In most cases the infection is restricted to the upper airways (nasal or throat epithelium) but it also can affect the lungs with severe consequences, such as pneumonia and considerable damage of the alveolar epithelial barrier in a fraction of the patients [2]. Infection with SARS-CoV-2 is confirmed by the detection of virus RNA in naso- and oropharyngeal swabs using quantitative real-time polymerase-chain reaction (qRT-PCR) [3]. Presence of viral RNA correlates with disease symptoms and cultivation/isolation of SARS-CoV-2 from these swabs [4]. Electron microscopy (EM) could demonstrate the virus in cell cultures treated with suspensions from broncho-alveolar lavage and thereby confirmed the identity of the virus as a coronavirus [5]. EM serves as an important control to demonstrate the presence of intact virus particles, because it is the only method which is able to demonstrate the virus particle (i.e. the infectious unit) itself and not only their molecular constituents (nucleic acids and protein) that could be present independently from an intact virus particle. Therefore, EM is essential in the histopathological analysis of infectious diseases caused by small pathogens, such as viruses, which are usually detected by antibodies or nuclear probes directed against distinct molecular targets of the pathogens. However, demonstration and analysis of SARS-CoV-2 particles by EM in patient samples is difficult as pointed out by a number of authors [68], and succeeded convincingly only in a few publications [912] (see [13] for a detailed review of the literature). Autopsy samples, which were, in contrast to biopsy samples, available in higher numbers, usually suffer from structural impairment by autolysis, due to the time interval between death and tissue conservation by fixation, which still may allow detection of viruses but interfere with the analysis of the ultrastructural pathology (e.g. the identification of affected cell types [7, 14]). Moreover, the virus most likely has been cleared already in many patients developing a fatal pneumonia, which would explain the difficulties to find virus particles in autopsy samples [11].
The upper airways are the best target for an analysis of the virus and the histopathology of the earlier phases of the COVID-19 disease because of the high virus RNA loads that can be measured. Biopsies would be suitable samples for studying such infections (e.g. [15]). However, biopsies are not medically indicated and are therefore not available for an investigation by EM. The most direct and minimal invasive way to get virus including, perhaps, infected cell samples from patients is to use the naso/oropharyngeal swabs obtained for qRT-PCR. Recently, virus structures at the surface of cells dried from swab suspensions could be demonstrated by scanning EM [16] but they lack the resolution which is necessary for a detailed analysis of particle ultrastructure and ultrastructural pathology of infection. Therefore, we applied a so far unpublished enrichment method for small volumes of virus suspensions to find SARS-CoV-2 in naso/oropharyngeal swab samples by thin section EM. The method involves sedimentation of a small volume (< = 100 µl) of swab suspension with an airfuge ultracentrifuge and resin embedding of the tiny pellet for thin sectioning. We provide a detailed protocol of the procedure, including a step-by-step embedding protocol, and demonstrate SARS-CoV-2 particles and infected cells.

Material and methods

Naso- and/or oropharyngeal swabs were taken from individuals by different operators using various standard swab collection systems (with and without transport medium). Dry swab brushes were transferred into 1 ml of phosphate-buffered saline (PBS). RNA extraction and qRT-PCR were conducted as described previously [17]. Determination of the virus variant was performed using validated mutation specific PCRs for SNP N501Y, deletion H69/V70 (unpublished), PCRs of the TaqMan SARS-CoV-2 mutation panel from Thermo Fisher Scientific, or by sequencing [18].
For thin section EM, we randomly selected nine samples with Ct values below 20 (a Ct value of 20.4 corresponds to 2 × 107 RNA copies/ml [19]), and two samples, which were negative by PCR (see Table 1). To concentrate the particles of the suspensions, we used desktop ultracentrifugation with an airfuge (Beckman Coulter) (see Fig. 1 for a graphic overview of the procedure). The sample suspensions (90 µl) were loaded on top of a cushion (25 µl) of low-melting point agarose (0.5% in water), which was filled and solidified in a standard airfuge vial (Beckman Coulter, Part. No. 342630). The suspensions were supplemented with 10 µl of glutaraldehyde (2.5% in 0.05 HEPES buffer, pH 7.2) and 20 µl of a gold colloid suspension (15 nm cationic gold; British Biocell) to further stabilize the biological particles and to stain the pellet by the red color of the concentrated gold colloid. Centrifugation was conducted for 10 min at room temperature and approx. 120.000×g (20 psi) using the fixed-angle A-100/18 rotor (Beckman Coulter, Part. No. 347593). After centrifugation, the supernatant was removed and the airfuge vial was filled with 100 µl of warm (approx. 40 °C) 3% low-melting point agarose, which was solidified on ice. The hardened agarose bloc was removed from the vial with a small spatula and the red pellet was covered by a drop of 3% low-melting point agarose to avoid dispersal during further preparation steps (see Additional file 1). Embedding for thin section electron microscopy was either performed according to a standard protocol, which involved post-fixation with osmium tetroxide, tannic acid and uranyl acetate before dehydration and embedding in Epon resin ([20]; see Additional file 2 for a step-by-step protocol), or by using rapid embedding in LR White after post-fixation with 1% osmium tetroxide for 30 min at room temperature ([21]; see Additional file 3 for a step-by-step protocol). Ultrathin sections were produced at a thickness between 60 and 70 nm using a diamond knife and an ultramicrotome (UC7, Leica Microsystems). Sections were collected on naked copper grids (300 or 300 × 75 mesh), stained with uranyl acetate followed by lead citrate and coated with carbon.
Table 1
List of naso-/oropharyngeal swabs tested
Sample No
PCR [Ct value)
Virus variant
Remarks
1
13.53
Alpha
Frozen
2
13.73
Delta
Frozen
3
18.06
Delta
Frozen
4
16.00
Delta
Frozen
5
17.40
Delta
Frozen
6
18.60
Delta
Non-frozen
7
14.30
Delta
Non-frozen
8
17.10
Delta
Non-frozen
9
16.60
Omicron
Frozen
10
Negative
-
Frozen
11
Negative
-
Frozen
Frozen = -80 °C
Non-frozen = storage at room or refrigerator temperature
Determination of the detection limit of the entire procedure was done using suspensions of Vaccinia virus at defined concentration (106 and 107 virus particles/ml). Virus propagation in cell culture and determination of particle concentration was done as described before [22]. Airfuge sedimentation was performed as described above, except that 100 µl of the sample suspension was used. The pellets were post-fixed and embedded in LR White as described above. Ultrathin sections (60–80 nm thickness) were collected on formvar-filmed slot grids and stained with a mixture of methyl cellulose and uranyl acetate [23].
Transmission EM of the sections was performed at 120 kV (Tecnai Spirit, Thermo Fisher) and images were recorded with a side-mounted CMOS camera (Phurona, EMSIS). Electron tomography was performed at 120 kV using a bottom mounted CCD camera (Eagle 4 k, Thermo Fisher) operated at 2048 by 2048 pixels and the Tecnai tomography software (Xplore 3D, version 2.4.2, Thermo Fisher Scientific). Reconstruction was done with the Inspect3D software (version 3.0, Thermo Fisher Scientific) using the “Simultaneous Iterative Reconstruction Technique “ (SIRT) algorithm (see [24] for a step-by-step description of the reconstruction).

Results

We selected nine naso/oropharyngeal swab samples from different persons which revealed Ct-values below 20 by RT-PCR and two swab samples that were RT-PCR-negative (Table 1) and concentrated the sample suspension by airfuge ultracentrifugation. The resulting tiny pellet was recovered and processed for conventional thin section electron microscopy. Embedded pellets were sectioned, contrasted and examined by transmission electron microscopy. We found coronavirus particles in the first or second level of sectioning in all of the nine samples that were positive by RT-PCR but not in sections of the two samples that were negative by RT-PCR. Coronavirus particles were intermingled between bacteria and unidentified structures of various morphologies, e.g. vesicular and crystalline (Fig. 2, Additional file 4: Fig. S1), or in and around eukaryotic cells (Fig. 3, Additional file 5: Fig. S2). The virus particle profiles revealed the characteristic features of coronaviruses [8], such as a size between 60 and 140 nm (without spikes), a limiting bio-membrane, a granular interior and club-shaped spikes (Figs. 2B, 3C-E, Additional file 4: Fig. S1 and Additional file 5: Fig. S2) which allowed distinguishing them from other profiles present in the samples (see Additional file 6: Fig. S3 for a comparison of virus particle profiles and other profiles found in a PCR-negative sample). However, the fraction of particles demonstrating the entire set of characteristic features was variable among the samples. In some of the samples, spikes were visible only rarely and distinct virus particle identification was only possible if the particles were localized at high number in membrane-bound compartments of cells [25]. Remarkably, samples which are demonstrating virus particles without or only few visible spikes were found among frozen and fresh samples. In addition, the virus particle interior often appeared very dense, in some cases entirely dark (Fig. 3C–E), which impairs with the detection of virus particles if spikes are not present. Electron tomography improved the z-resolution and revealed interior substructure and spikes much better than standard imaging of the thin sections (Additional file 7: Fig. S4).
The size of coronavirus particles and their spike number measured in swab samples, in which the virus particle profiles generally showed spikes, were similar to the size and spike number measured in Vero cell culture (Table 2; see [24] for details of the Vero cell culture infection experiments and virus particle measurements using sections at 45 nm thickness). However, it is notable that the virus particles of the two measured swab samples showed a slightly smaller spike number per profile than the respective virus variant in cell culture. Moreover, the virus particles of swab sample 7 demonstrated a smaller shape factor “roundness”, along with a higher variability of the size, than the particles measured in the other samples which indicates a deviation from round/oval shape of the virus particles in sample 7. Virus particles in the swab samples sometimes appear compressed or irregular in shape. Such a systematic deviation from the usual round/oval shape of the particles most probably was responsible for the small difference in size (maximum diameter) measured for the virus particles of swab sample 7 in comparison to the virus particles of the same virus variant in cell culture, which revealed a rounder shape (Table 2).
Table 2
Virus particles size, shape and spike number
Sample ID
Virus variant
Maximal diameter [nm]
Perimeter [nm]
Shape factor "roundness"
Spike number per profile
Virus particles measured
Swab sample 1
Alpha
92 (6)
283 (16)
0.93 (0.04)
8 (5)
100
Cell culture
Alpha
93 (6)
284 (14)
0.94 (0.05)
10 (4)
153
Swab sample 7
Delta
96 (14)
287 (28)
0.85 (0.13)
9 (5)
100
Cell culture
Delta
92 (6)
281 (18)
0.92 (0.05)
10 (4)
153
Measurements are represented as their median with inter quartile range in brackets
The composition of the swab samples regarding bacteria and eukaryotic cells varied considerably among the swab samples studied, regardless of their virus content. Bacteria were found in all samples (see Fig. 2, Additional file 4: Fig. S1 and Additional file 5: Fig. S2), while coccoid bacteria were more frequently found than rod-like bacteria. Keratinocytes from the epidermal regions of the naso/oropharyngeal cavities were prominent in all samples studied (Additional file 4: Fig. S1, Additional file 5: Fig. S2, and Additional file 6: Fig. S3). Ciliated cells were only detected in some of the samples (Fig. 3, Additional file 8: Fig. S5A) and occasionally some of them were infected and demonstrated coronavirus particles within membrane-bound compartments of the cytoplasm (Fig. 3). Moreover, in few of the infected ciliated cells, typical double-membrane vesicles (DMVs) could be detected (Fig. 3A, Additional file 7: Fig. S4B), which indicate virus replication in the respective cell [26]. It is of note that some of the cells appeared relatively intact and only slightly structurally affected by the entire sampling and preparation procedures (Additional file 8: Fig. S5). However, while bacteria and keratinocytes were sufficiently preserved in all samples regardless of the storage conditions, other cells reveal significant damage (e.g. perforated bio-membranes) in frozen samples (Additional file 9: Fig. S6).
To investigate whether rapid embedding could be used to investigate the swab samples or not, we post-fixed airfuge sediments of three swab samples with 1% osmium tetroxide (30 min) and embedded them in LR White resin [21] (the polymerization time was adjusted to 1 h). The entire embedding procedure lasted about 2 h. Coronavirus particles were found in all samples embedded in LR White. However, virus particles were much more difficult to identify than in the samples embedded in Epon resin, because the spikes were hardly visible in most of the virus particles (Fig. 4A). And this was specific for the LR White protocol used because swab sample 7 was embedded in both resins, Epon and LR White, and clearly revealed spikes only after Epon embedding (compare Fig. 3 with Fig. 4). A reliable identification of coronavirus particles in the LR White embedded samples was only possible if the particles were found in cells in which they typically aggregated in membrane-bound compartments of the cytoplasm (Fig. 4B; [25]).
We selected swab samples which most likely contained a high concentration of virus particles according to the RT-PCR measurements of the virus RNA load. To get an idea about the detection limit of our airfuge sedimentation method, we sedimented Vaccinia virus suspension at two defined concentrations (106 and 107 particles/ml; see [22] for a description of the determination of the actual particle concentration) and embedded the pellets in LR White (Additional file 10: Fig. S7). With a suspension of 107 particles/ml, virus particles could be found in the first section through each of the pellets (3 of 3 samples), while with a suspension of 106 particles/ml only part of the pellets showed virus in the first Section (6 of 8 samples).

Discussion

Concentration of particles from naso-/oropharyngeal swabs by airfuge ultracentrifugation allowed the visualization of SARS-CoV-2 particles by thin section EM. Airfuge centrifugation in electron microscopy was mainly used in conjunction with negative staining of particles to increase particle number adsorbed at the sample carriers [27, 28]. Sample concentration of virus particles for thin section EM was usually performed by using larger ultracentrifuges which allow the processing of larger volumes (i.e. several tens of milliliters) from cell culture and the usage of density gradients for purification (e.g. [29]). Our new method concentrates all particles from a small volume of suspension obtained from a naso-/oropharyngeal swab sample within a comparatively short time (approximately 20 min) and thereby making them accessible for thin section electron microscopy.
Virus particles could be detected in the extracellular space and within ciliated cells, which is the main target cell of the virus in the upper airways [9, 10]. Remarkably, infected cells occasionally revealed replication organelles, such as double-membrane vesicles (DMVs), which are typical for coronavirus infected cell cultures [26]. Recently, DMVs were also demonstrated in infected alveolar cells from autopsy tissue [12].
The swab samples contained other cells and material besides virus particles and ciliated cells, mainly keratinocytes from the upper layers of the epidermis and, mostly coccoid, bacteria. Vesicular and needle-like crystal aggregates formed the background matrix, which most probably derived from cells or the swab material, respectively. The preservation of the keratinocytes, bacteria, viruses and background material was similar in frozen and non-frozen samples, while other cells, in particular ciliated cells, appeared extracted in the swab samples that were frozen. Thus, for optimal preservation of cells, especially if the cell biology of the virus is of interest, fresh swab samples should be considered. For diagnostic purposes, even frozen material is suitable.
The coronavirus morphology seemed to be independent from the storage conditions (i.e. frozen or non-frozen) but was sample-dependent. Some samples showed many deformed particles and/or only virus particles without spikes. Deformation of virus particles and spike visibility in infected cell culture are most probably due to false or incomplete assembly at later stages of infection or virus production in cell culture [30]. It can be expected that at least in some patients the infection already lasted for a few days until the swab sample was taken and then contain mainly virus particles from later cellular infection stages which could reveal deformations and/or less spikes, like the particles in later stages of infected cell cultures. We measured the particle size and spike density of virus particles in two randomly selected swab samples (selection criterion: visible spikes) and compared them with the size and spike density of virus particles of the same virus variant in cell culture. The size of particles was very similar and only slightly elevated by 3–4 nm in swab sample 7, which revealed also a reduced roundness indicating a deformation of the particles. The spike density of the particle profiles was also similar, with a slight tendency to lower spike numbers in the swab samples, which could be due to a reduced visibility, a reduced integration (as discussed above) or a loss of spikes. However, the spike numbers per virus profile indicate that the virus particles in patients possess a similar number of spikes (i.e. 20–25 spikes per virus particle; see [24]) as viruses in cell culture, if the spikes are generally present.
The sedimentation method for swab suspensions presented here is compatible with embedding in epoxy and acrylic resin, including rapid infiltration and polymerization. This allows using the method for rapid diagnostics in cases of emergencies, for instance, the emergence of unknown or unconventional pathogens. However, spike visibility was reduced after osmium tetroxide post-fixation and rapid embedding in the acrylic resin LR White. Block-contrasting with tannic acid and/or uranyl acetate, as performed in the epoxy embedding protocol, could probably help to increase spike visibility, but would increase processing time and limiting the benefit of using LR White. In case of SARS-CoV-2, the reduced spike visibility was not relevant for diagnostics because the viruses could be identified by finding them in intracellular membrane-bound compartments in high numbers which is a typical feature of coronaviruses [25].
A requirement for a fast detection of viruses by thin section EM using the sedimentation method described in this paper is a comparatively high particle concentration of the swab suspension. According to experiments with Vaccinia virus suspensions of defined concentration, a particle concentration of 107 particles/ml is necessary to allow an immediate detection of viruses without performing an extensive search of several sections at the microscope. At 106 particles/ml not all of the samples revealed viruses in the first section through the pellet, which would require taking more sections and extended time for microscopy. The SARS-CoV-2-positive swab samples used in this study contained RNA loads far above approx. 107 copies/ml (Ct 20.4 corresponds to 2 × 107 RNA copies/ml; [19]). It was therefore not surprising that we could find coronaviruses in all of the swab samples tested. However, it is still unclear what the relationship is between the number of RNA copies detected and the number of virus particles present. From cultivation assays it is known that already at a viral RNA load of 106 particles per ml the cultivation success drops to 50% of the cultures infected [4] which indicates that at least the fraction of infectious virus is much lower than the RNA load. Using our novel method could help to investigate the reason for this observation and clarify how many virus particles are present and in which condition. A reduced spike availability at the particle surface, as observed in some of the samples investigated here (see above), could be an explanation.
In summary, we presented a method for thin section EM of naso/oropharyngeal swab samples, which allows the detection and analysis of SARS-CoV-2 particles in the extra- and intracellular context of the acute phase of the infection, thereby complementing studies using autopsies, biopsies and cell cultures. The method could be relevant for the study of further virus variants of concern or of other emerging infectious pathogens affecting the upper respiratory tract, because it offers direct and easy access to the pathogens produced by the natural host including infected or affected cells for the study of their pathogenesis. Moreover, it is likely that the method could be extended to other sample types, such as broncho-alveolar lavage or urine.

Acknowledgements

The authors would like to thank Andrea Schnartendorff for preparing the artwork of Fig. 1 and Christoph Schaudinn for valuable suggestions on the manuscript.

Declarations

Swab samples from individuals were used in anonymized form. Sample usage obtained ethical approval by the Berliner Ärztekammer (Eth 20/40).
Not applicable.

Competing interests

The authors declare that they have no financial and non-financial competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Anhänge

Supplementary Information

Additional file 1: Video S1. Recovery of the sediment after ultracentrifugation
Literatur
2.
Zurück zum Zitat Osuchowski MF, Winkler MS, Skirecki T, Cajander S, Shankar-Hari M, Lachmann G, et al. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir Med. 2021;9:622–42.CrossRef Osuchowski MF, Winkler MS, Skirecki T, Cajander S, Shankar-Hari M, Lachmann G, et al. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir Med. 2021;9:622–42.CrossRef
4.
Zurück zum Zitat Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, et al. Virological assessment of hospitalized cases of coronavirus disease 2019. Nature. 2020;581:465–9.CrossRef Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, et al. Virological assessment of hospitalized cases of coronavirus disease 2019. Nature. 2020;581:465–9.CrossRef
5.
Zurück zum Zitat Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–33.CrossRef Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–33.CrossRef
10.
Zurück zum Zitat Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24:168–75.CrossRef Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24:168–75.CrossRef
11.
Zurück zum Zitat Cortese K, Holland G, Möller L, Gagliani MC, Barisione E, Ball L, et al. Ultrastructural examination of lung “cryobiopsies” from a series of fatal COVID-19 cases hardly revealed infected cells. Virchows Arch. 2022;480:967–77.CrossRef Cortese K, Holland G, Möller L, Gagliani MC, Barisione E, Ball L, et al. Ultrastructural examination of lung “cryobiopsies” from a series of fatal COVID-19 cases hardly revealed infected cells. Virchows Arch. 2022;480:967–77.CrossRef
12.
Zurück zum Zitat Kataoka M, Tsukamoto T, Tajima Y, Sato Y, Katano H, Suzuki T, et al. Coronavirus hunted in human pneumocytes and alveolar macrophages: a case report. Histopathology. 2022;80:1130–4.CrossRef Kataoka M, Tsukamoto T, Tajima Y, Sato Y, Katano H, Suzuki T, et al. Coronavirus hunted in human pneumocytes and alveolar macrophages: a case report. Histopathology. 2022;80:1130–4.CrossRef
13.
14.
Zurück zum Zitat Dittmayer C, Meinhardt J, Radbruch H, Radke J, Ingold Heppner B, Heppner FH, et al. Using EM data to understand COVID-19 pathophysiology–Authors’ reply. Lancet. 2021;397:197–8.CrossRef Dittmayer C, Meinhardt J, Radbruch H, Radke J, Ingold Heppner B, Heppner FH, et al. Using EM data to understand COVID-19 pathophysiology–Authors’ reply. Lancet. 2021;397:197–8.CrossRef
15.
Zurück zum Zitat Afzelius BA. Ultrastructure of human nasal epithelium during an episode of coronavirus infection. Virchows Arch. 1994;24:295–300.CrossRef Afzelius BA. Ultrastructure of human nasal epithelium during an episode of coronavirus infection. Virchows Arch. 1994;24:295–300.CrossRef
16.
Zurück zum Zitat Mondeja B, Valdes O, Resik S, Vizcaino A, Acosta E, Montalván A, et al. SARS-CoV-2: preliminary study of infected human nasopharyngeal tissue by high resolution microscopy. Virol J. 2021;18:149.CrossRef Mondeja B, Valdes O, Resik S, Vizcaino A, Acosta E, Montalván A, et al. SARS-CoV-2: preliminary study of infected human nasopharyngeal tissue by high resolution microscopy. Virol J. 2021;18:149.CrossRef
18.
Zurück zum Zitat Brinkmann A, Ulm SL, Uddin S, Förster S, Seifert D, Oehme R, et al. AmpliCoV: rapid Whole-genome sequencing using multiplex pcr amplification and real-time oxford nanopore minion sequencing enables rapid variant identification of SARS-CoV-2. Front Microbiol. 2021;12: 651151.CrossRef Brinkmann A, Ulm SL, Uddin S, Förster S, Seifert D, Oehme R, et al. AmpliCoV: rapid Whole-genome sequencing using multiplex pcr amplification and real-time oxford nanopore minion sequencing enables rapid variant identification of SARS-CoV-2. Front Microbiol. 2021;12: 651151.CrossRef
20.
Zurück zum Zitat Laue M. Electron microscopy of viruses. Methods Cell Biol. 2010;96:1–20.CrossRef Laue M. Electron microscopy of viruses. Methods Cell Biol. 2010;96:1–20.CrossRef
21.
Zurück zum Zitat Laue M, Niederwöhrmeier B, Bannert N. Rapid diagnostic thin section electron microscopy of bacterial endospores. J Microbiol Methods. 2007;70:45–54.CrossRef Laue M, Niederwöhrmeier B, Bannert N. Rapid diagnostic thin section electron microscopy of bacterial endospores. J Microbiol Methods. 2007;70:45–54.CrossRef
22.
Zurück zum Zitat Laue M, Bannert N. Detection limit of negative staining electron microscopy for the diagnosis of bioterrorism-related microorganisms. J Appl Microbiol. 2010;109:1159–66.CrossRef Laue M, Bannert N. Detection limit of negative staining electron microscopy for the diagnosis of bioterrorism-related microorganisms. J Appl Microbiol. 2010;109:1159–66.CrossRef
23.
Zurück zum Zitat Roth J, Taatjes DJ, Tokuyasu KT. Contrasting of Lowicryl K4M thin sections. Histochemistry. 1990;95:123–36.CrossRef Roth J, Taatjes DJ, Tokuyasu KT. Contrasting of Lowicryl K4M thin sections. Histochemistry. 1990;95:123–36.CrossRef
25.
Zurück zum Zitat Bullock HA, Goldsmith CS, Miller SE. Best practices for correctly identifying coronavirus by transmission electron microscopy. Kidney Int. 2021;99:824–7.CrossRef Bullock HA, Goldsmith CS, Miller SE. Best practices for correctly identifying coronavirus by transmission electron microscopy. Kidney Int. 2021;99:824–7.CrossRef
26.
Zurück zum Zitat Ogando NS, Dalebout TJ, Zevenhoven-Dobbe JC, Limpens RWAL, van der Meer Y, Caly L, et al. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology. J Gen Virol. 2020;101:925–40.CrossRef Ogando NS, Dalebout TJ, Zevenhoven-Dobbe JC, Limpens RWAL, van der Meer Y, Caly L, et al. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology. J Gen Virol. 2020;101:925–40.CrossRef
27.
Zurück zum Zitat Hammond GW, Hazelton PR, Chuang I, Klisko B. Improved detection of viruses by electron microscopy after direct ultracentrifuge preparation of specimens. J Clin Microbiol. 1981;14:210–21.CrossRef Hammond GW, Hazelton PR, Chuang I, Klisko B. Improved detection of viruses by electron microscopy after direct ultracentrifuge preparation of specimens. J Clin Microbiol. 1981;14:210–21.CrossRef
28.
Zurück zum Zitat Biel SS, Gelderblom HR. Diagnostic electron microscopy is still a timely and rewarding method. J Clin Virol. 1999;13:105–19.CrossRef Biel SS, Gelderblom HR. Diagnostic electron microscopy is still a timely and rewarding method. J Clin Virol. 1999;13:105–19.CrossRef
29.
Zurück zum Zitat Carrascosa AL, del Val M, Santarén JF, Viñuela E. Purification and properties of African swine fever virus. J Virol. 1985;54:337–44.CrossRef Carrascosa AL, del Val M, Santarén JF, Viñuela E. Purification and properties of African swine fever virus. J Virol. 1985;54:337–44.CrossRef
30.
Zurück zum Zitat Eymieux S, Rouillé Y, Terrier O, Seron K, Blanchard E, Rosa- Calatrava M, et al. Ultrastructural modifications induced by SARS-CoV-2 in Vero cells: a kinetic analysis of viral factory formation, viral particle morphogenesis and virion release. Cell Mol Life Sci. 2021;78:3565–76.CrossRef Eymieux S, Rouillé Y, Terrier O, Seron K, Blanchard E, Rosa- Calatrava M, et al. Ultrastructural modifications induced by SARS-CoV-2 in Vero cells: a kinetic analysis of viral factory formation, viral particle morphogenesis and virion release. Cell Mol Life Sci. 2021;78:3565–76.CrossRef
Metadaten
Titel
Visualization of SARS-CoV-2 particles in naso/oropharyngeal swabs by thin section electron microscopy
verfasst von
Michael Laue
Tobias Hoffmann
Janine Michel
Andreas Nitsche
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
Virology Journal / Ausgabe 1/2023
Elektronische ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-023-01981-9

Weitere Artikel der Ausgabe 1/2023

Virology Journal 1/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.